Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse on Driving Performance in Young Adults With ADHD
NCT00801229Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started Dec 2008; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00801229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801229.